Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment.
Translational cancer research(2023)
摘要
These results indicate that clusterin is connected to prognosis of breast cancer patients and tumor immune cell infiltration. This demonstrates that clusterin may be a biomarker of immune cell recruitment into breast tumors and an important biomarker for immune cell infiltration; consequently being a valuable prognostic factor in breast cancer patients.
更多查看译文
关键词
Breast cancer,biomarker,clusterin (CLU),prognosis,tumor infiltration
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要